Report of Foreign Issuer (6-k)
January 18 2013 - 10:45AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13a-16 OR 15d-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of January 2013
Commission File Number: 1-32186
(Translation of registrant's name into English)
|
|
Suite 400, Building 11
5045 Orbiter Drive
Mississauga, Ontario
Canada L4W 4Y4
|
(Address of principal executive offices)
|
Indicate by check mark whether the registrant files or will file
annual reports under cover of Form 20-F or Form 40-F.
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1)
o
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7)
o
DOCUMENTS FILED
See the Exhibit Index hereto.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
YM BIOSCIENCES INC.
|
|
|
|
|
|
By:
|
/s/ Leonard Vernon
|
|
|
Leonard Vernon
Vice President, Finance and Administration
|
Date: January 18, 2013
EXHIBIT INDEX
Exhibit
|
|
Description
|
|
|
|
99.1
|
|
News Release Dated January 18, 2013 - YM BioSciences Inc. Plan of Arrangement with Gilead Sciences, Inc. Endorsed by Leading Independent Proxy Advisors
ISS and Glass Lewis
|
YM Biosciences (AMEX:YMI)
Historical Stock Chart
From Apr 2024 to May 2024
YM Biosciences (AMEX:YMI)
Historical Stock Chart
From May 2023 to May 2024